127 related articles for article (PubMed ID: 498164)
1. A well tolerated oral combination of chlorambucil (Leukeran R), methotrexate, fluorouracil, prednisone (LMFP) in disseminated breast cancer.
Mayr AC; Jungi WF; Senn HJ
Cancer Treat Rev; 1979 Jun; 6 Suppl():115-20. PubMed ID: 498164
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.
Senn HJ; Mayr AC
Cancer Treat Rev; 1979 Jun; 6 Suppl():79-85. PubMed ID: 387231
[No Abstract] [Full Text] [Related]
3. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
4. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
5. [Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Cavalli F; Beer M; Martz G; Jungi WF; Alberto P; Obrecht JP; Mermillod B; Brunner KW
Schweiz Med Wochenschr; 1982 May; 112(22):774-83. PubMed ID: 7048518
[TBL] [Abstract][Full Text] [Related]
6. Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
Carmo-Pereira J; Costa FO; Henriques E
Eur J Cancer (1965); 1980 Dec; 16(12):1621-5. PubMed ID: 7014228
[No Abstract] [Full Text] [Related]
7. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
[TBL] [Abstract][Full Text] [Related]
8. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC
Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472
[No Abstract] [Full Text] [Related]
9. Chemotherapy for breast cancer.
Sarg MJ
J Reprod Med; 1979 Jul; 23(1):3-11. PubMed ID: 226698
[No Abstract] [Full Text] [Related]
10. [Results of "5-drug" treatment of advanced breast cancer].
Dorociak R
Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
[No Abstract] [Full Text] [Related]
11. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
12. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
13. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
[No Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
Senn HJ; Maibach R; Castiglione M; Jungi WF; Cavalli F; Leyvraz S; Obrecht JP; Schildknecht O; Siegenthaler P
J Clin Oncol; 1997 Jul; 15(7):2502-9. PubMed ID: 9215818
[TBL] [Abstract][Full Text] [Related]
15. The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Stout R; Todd ID
Cancer Treat Rev; 1979 Jun; 6 Suppl():107-13. PubMed ID: 498163
[No Abstract] [Full Text] [Related]
16. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
Friedman MA; Marcus F; Kohler M; Resser KJ
Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
[No Abstract] [Full Text] [Related]
17. [Combination chemotherapy in advanced carcinoma of the breast].
Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
[No Abstract] [Full Text] [Related]
18. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D; Gelman R; Falkson G
Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
[No Abstract] [Full Text] [Related]
19. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
20. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Carmo-Pereira J; Costa FO; Henriques E
Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]